123 related articles for article (PubMed ID: 23868068)
21. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy.
Kee HJ; Eom GH; Joung H; Shin S; Kim JR; Cho YK; Choe N; Sim BW; Jo D; Jeong MH; Kim KK; Seo JS; Kook H
Circ Res; 2008 Nov; 103(11):1259-69. PubMed ID: 18849323
[TBL] [Abstract][Full Text] [Related]
22. 17beta-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats.
Shenoy V; Grobe JL; Qi Y; Ferreira AJ; Fraga-Silva RA; Collamat G; Bruce E; Katovich MJ
Peptides; 2009 Dec; 30(12):2309-15. PubMed ID: 19747516
[TBL] [Abstract][Full Text] [Related]
23. Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension.
Kee HJ; Kim I; Jeong MH
Biochem Pharmacol; 2022 Aug; 202():115111. PubMed ID: 35640713
[TBL] [Abstract][Full Text] [Related]
24. HDAC6 Promotes Cardiac Fibrosis Progression through Suppressing RASSF1A Expression.
Tao H; Yang JJ; Hu W; Shi KH; Li J
Cardiology; 2016; 133(1):18-26. PubMed ID: 26401643
[TBL] [Abstract][Full Text] [Related]
25. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats.
Bae EH; Kim IJ; Ma SK; Kim SW
Hypertens Res; 2010 Mar; 33(3):255-62. PubMed ID: 20057489
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
[TBL] [Abstract][Full Text] [Related]
28. Sesame oil therapeutically ameliorates cardiac hypertrophy by regulating hypokalemia in hypertensive rats.
Liu CT; Periasamy S; Chang CC; Mo FE; Liu MY
JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):750-7. PubMed ID: 23753993
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.
Loch D; Hoey A; Brown L
Clin Exp Hypertens; 2006 Jul; 28(5):475-88. PubMed ID: 16820344
[TBL] [Abstract][Full Text] [Related]
30. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
Loch D; Levick S; Hoey A; Brown L
J Cardiovasc Pharmacol; 2006 Mar; 47(3):396-404. PubMed ID: 16633082
[TBL] [Abstract][Full Text] [Related]
31. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
Xia CF; Bledsoe G; Chao L; Chao J
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F622-31. PubMed ID: 15886273
[TBL] [Abstract][Full Text] [Related]
32. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes.
Nakagawa Y; Kuwahara K; Harada M; Takahashi N; Yasuno S; Adachi Y; Kawakami R; Nakanishi M; Tanimoto K; Usami S; Kinoshita H; Saito Y; Nakao K
J Mol Cell Cardiol; 2006 Dec; 41(6):1010-22. PubMed ID: 17011572
[TBL] [Abstract][Full Text] [Related]
33. A proteasome inhibitor prevents vascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
Takaoka M; Ohkita M; Itoh M; Kobayashi Y; Okamoto H; Matsumura Y
Clin Exp Pharmacol Physiol; 2001; 28(5-6):466-8. PubMed ID: 11380524
[TBL] [Abstract][Full Text] [Related]
34. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Brown L; Duce B; Miric G; Sernia C
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
[TBL] [Abstract][Full Text] [Related]
35. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
[TBL] [Abstract][Full Text] [Related]
36. Renoprotective effects of sildenafil in DOCA-salt hypertensive rats.
Bae EH; Kim IJ; Joo SY; Kim EY; Kim CS; Choi JS; Ma SK; Kim SH; Lee JU; Kim SW
Kidney Blood Press Res; 2012; 36(1):248-57. PubMed ID: 23171857
[TBL] [Abstract][Full Text] [Related]
37. Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.
Mirkovic S; Seymour AM; Fenning A; Strachan A; Margolin SB; Taylor SM; Brown L
Br J Pharmacol; 2002 Feb; 135(4):961-8. PubMed ID: 11861324
[TBL] [Abstract][Full Text] [Related]
38. Altered cardiac endothelin receptors and protein kinase C in deoxycorticosterone-salt hypertensive rats.
Fareh J; Touyz RM; Schiffrin EL; Thibault G
J Mol Cell Cardiol; 2000 Apr; 32(4):665-76. PubMed ID: 10756122
[TBL] [Abstract][Full Text] [Related]
39. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.
Vannini A; Volpari C; Filocamo G; Casavola EC; Brunetti M; Renzoni D; Chakravarty P; Paolini C; De Francesco R; Gallinari P; Steinkühler C; Di Marco S
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15064-9. PubMed ID: 15477595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
